Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

I present 10 high-yield investment picks for May 2025, offering strong dividend income and growth potential. Read how ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

The Food and Drug Administration has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S. and internationally. It will report its Q1 2025 earnings on April 29.

Pfizer Inc. (PFE) is a multinational pharmaceutical ... These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research ...